|
Volumn 27, Issue 9, 2008, Pages 942-946
|
Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
COBALT;
FLUOROURACIL;
IRIDIUM;
PACLITAXEL;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
BRACHYTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RADIOISOTOPE THERAPY;
RANDOMIZED CONTROLLED TRIAL;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
UTERINE CERVIX TUMOR;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BRACHYTHERAPY;
CARBOPLATIN;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COBALT RADIOISOTOPES;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
IRIDIUM RADIOISOTOPES;
MIDDLE AGED;
NEOPLASM STAGING;
PACLITAXEL;
RADIOISOTOPE TELETHERAPY;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
|
EID: 77955418191
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|